Combination treatment with infliximab and leflunomide in patients with active rheumatoid arthritis:: Safety and efficacy in an open-label clinical trial

被引：0
|
作者：
Antoni, CE
Nüsslein, HG
Wollenhaupt, J
Burmester, GR
Krüger, K
Kalden, JR
机构：
[1] Univ Erlangen Nurnberg, Med Klin & Poliklin 3, D-8520 Erlangen, Germany
[2] Stadt Klinikum Dresden, Med Klin Friedrichstadt 1, Dresden, Germany
[3] Allgemeines Krankenhaus Eilbek, Abt Rheumatol & Klin Immunol, Hamburg, Germany
[4] Univ Berlin, Charite, Med Klin Rheumatol, Berlin, Germany
[5] Rheumazentrum, Munich, Germany
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2004年 / 63卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：276 / 276
页数：1
相关论文
共 50 条
  • [41] Long term safety and efficacy of open-label infliximab for SLE
    Aringer, M.
    Houssiau, F.
    Graninger, W. B.
    Feier, E.
    Steiner, G.
    Smolen, J. S.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 455 - 455
  • [42] Safety of Methotrexate and Leflunomide Combination Therapy in the Treatment of Rheumatoid Arthritis
    Badilla, Maria
    Moldenhauer, Nicia
    Neira, Diego
    Munoz, Luis
    Neira, Oscar
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [43] Evaluation of efficacy of combination of methotrexate and hydroxychloroquine with leflunomide in active rheumatoid arthritis
    Shashikumar, N. S.
    Shivamurthy, M. C.
    Chandrashekara, S.
    INDIAN JOURNAL OF PHARMACOLOGY, 2010, 42 (06) : 358 - 361
  • [44] OPEN-LABEL TREATMENT OF RHEUMATOID-ARTHRITIS (RA) - EFFICACY AND TOLERABILITY OF NABUMETONE
    SPREKELER, R
    BRITISH JOURNAL OF RHEUMATOLOGY, 1992, 31 : 164 - 164
  • [45] Open label study to assess infliximab safety and timing of onset of clinical benefit among patients with rheumatoid arthritis
    Shergy, WJ
    Isern, RA
    Cooley, DA
    Harshbarger, JL
    Huffstutter, JE
    Hughes, GM
    Spencer-Smith, EA
    Goldman, AL
    Roth, SH
    Toder, JS
    Warner, D
    Quinn, A
    Keenan, GF
    Schaible, TF
    JOURNAL OF RHEUMATOLOGY, 2002, 29 (04) : 667 - 677
  • [46] Methotrexate and leflunomide combination therapy for patients with active rheumatoid arthritis
    Mroczkowski, PJ
    Weinblatt, ME
    Kremer, JM
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 1999, 17 (06) : S66 - S68
  • [47] A PROSPECTIVE, OBSERVATIONAL STUDY ON THE CLINICAL EFFICACY AND SAFETY OF LEFLUNOMIDE IN EGYPTIAN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS: CLEAR STUDY
    Elsayed, Adel
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1672 - 1673
  • [48] A comparison of the efficacy and safety of leflunomide and methotrexate for the treatment of rheumatoid arthritis
    Emery, P
    Breedveld, FC
    Lemmel, EM
    Kaltwasser, JP
    Dawes, PT
    Gömör, B
    Van den Bosch, F
    Nordström, D
    Bjorneboe, O
    Dahl, R
    Horslev-Petersen, K
    de la Serna, AR
    Molloy, M
    Tikly, M
    Oed, C
    Rosenburg, R
    Loew-Friedrich, I
    RHEUMATOLOGY, 2000, 39 (06) : 655 - 665
  • [49] Safety and efficacy of combination therapy of iguratimod with methotrexate for patients with active rheumatoid arthritis with an inadequate response to methotrexate: An open-label extension of a randomized, double-blind, placebo-controlled trial
    Hara, Masako
    Ishiguro, Naoki
    Katayama, Kou
    Kondo, Masakazu
    Sumida, Takayuki
    Mimori, Tsuneyo
    Soen, Satoshi
    Nagai, Kota
    Yamaguchi, Tomonobu
    Yamamoto, Kazuhiko
    MODERN RHEUMATOLOGY, 2014, 24 (03) : 410 - 418
  • [50] Efficacy of infliximab in the treatment of uveitis that is resistant to treatment with the combination of azathioprine, cyclosporine, and corticosteroids in Behcet's disease -: An open-label trial
    Tugal-Tutkun, I
    Mudun, A
    Urgancioglu, M
    Kamali, S
    Kasapoglu, E
    Inanc, M
    Gül, A
    ARTHRITIS AND RHEUMATISM, 2005, 52 (08): : 2478 - 2484
12345